AmTech, headquartered in Shenzhen, China, is an innovative high-tech enterprise founded in September 2017. AmTech specializes in the R&D and manufacturing of high-end IVD reagents (Enzymatic Assay, Immunoturbidimetric Assay, and Chemiluminescent Immunoassay), instruments and biological raw materials for clinical and research labs.
The mission of AmTech is to become a world first class biotech enterprise driven by innovation and make significant contribution to the development of science and technology in the world. With eight state-of-the-art technology platforms, we have built a solid foundation for breakthrough discoveries. Key among our technological advancements is the biomacromolecule point to point covalent bioconjugation platform, which forms the basis for developing high-quality products. Additionally, our tunable gene recombination platform serves as an essential tool for R&D and manufacturing of biological raw materials. So far, we have filed over 40 patents, with more than 20 successfully granted.
